2m 2m 2m 2m 2m 2m 2m
Cellectis Sp ADR (CLLS)
NASDAQ
$3.11-$0.27 (-7.99%)
Price as of Jun 03, 2026 7:14 PM EDT- $255.6MMarket Cap
- 131.51%1-Year Change
- BiotechnologyIndustry
Cellectis Sp ADR (CLLS)
$3.11-$0.27 (-7.99%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 72.9M +75.76% | 41.5M +5,397.35% | 755,000 -96.06% | 19.2M -66.54% | |
Cost of Revenue | 0 N/A | 0 -100.00% | 737,000 -58.41% | 1.8M -94.35% | |
Gross Profit | 72.9M +75.76% | 41.5M +230,483.33% | 18,000 -99.90% | 17.4M -32.91% | |
Sales and Marketing Expense | 19.8M +3.69% | 19.1M +13.52% | 16.8M -3.90% | 17.5M -53.80% | |
Research and Development Expense | -93.5M +3.29% | -90.5M +3.30% | -87.6M -10.11% | -97.5M -24.44% | |
Depreciation and Amortization Expense | 20.1M +1.09% | 19.8M +7.14% | 18.5M +0.48% | 18.4M +11.26% | |
Total Operating Expenses | 19.8M +3.69% | 19.1M +13.52% | 16.8M -3.90% | 17.5M -53.80% | |
Operating Profit | -33.1M -44.46% | -59.6M -38.79% | -97.3M +8.52% | -89.7M -31.38% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -300,000 +200.00% | -100,000 N/A | N/A N/A | -371,000 +4.51% | |
Interest Income and Expense and Net | -300,000 +200.00% | -100,000 N/A | 0 +100.00% | -371,000 +4.51% | |
Total Nonoperating Income and Expense | 6.6M -13.85% | 7.7M -8.60% | 8.4M +28.77% | 6.6M -32.98% | |
Income before Taxes | -67.6M +83.87% | -36.8M -66.10% | -108.4M -4.90% | -114.0M -8.85% | |
Income Taxes | -423,000 N/A | 0 -100.00% | 371,000 +526.44% | -87,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -67.6M +83.87% | -36.8M -66.10% | -108.4M -4.90% | -114.0M -8.85% | |
Net Income from Continuing Operations Applicable to Common | -67.6M +83.87% | -36.8M -66.10% | -108.4M -4.90% | -114.0M -8.85% | |
Basic EPS and Net Income | -0.67 +63.41% | -0.41 -76.84% | -1.77 -24.03% | -2.33 -8.63% | |
Diluted EPS and Net Income | -0.67 +63.41% | -0.41 -76.84% | -1.77 -24.03% | -2.33 -8.63% | |
Basic Weighted Average Shares | 100.3M +10.72% | 90.6M +58.85% | 57.0M +25.17% | 45.5M +1.62% | |
Diluted Weighted Average Shares | 100.3M +10.72% | 90.6M +58.85% | 57.0M +25.17% | 45.5M +1.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 61.5M -57.05% | 143.3M +4.79% | 136.7M +52.25% | 89.8M -51.63% | |
Short-Term Investments | N/A N/A | 1.2M -87.23% | 9.4M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 61.5M -57.40% | 144.5M -1.13% | 146.1M +62.72% | 89.8M -51.63% | |
Total Current Assets | N/A N/A | 32.9M +521.04% | 5.3M -95.66% | 122.0M -45.86% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 38.8M -15.49% | 45.9M -16.07% | 54.7M -14.05% | 63.6M -19.31% | |
Total Long-Term Assets | 88.5M -8.29% | 96.5M -4.73% | 101.3M -13.75% | 117.4M -25.05% | |
Total Assets | 324.7M -15.34% | 383.5M +14.74% | 334.3M +27.97% | 261.2M -31.63% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 145.8M -12.34% | 166.3M +7.17% | 155.1M +222.34% | 48.1M -2.47% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 103.1M +19.51% | 86.2M -8.67% | 94.4M +30.65% | 72.3M -24.91% | |
Total Liabilities | 248.8M -1.46% | 252.5M N/A | N/A N/A | N/A N/A | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 75.9M -42.07% | 131.0M +54.71% | 84.7M -32.75% | 125.9M -46.74% | |
Total Shares Outstanding | 100.3M +0.25% | 100.1M +39.50% | 71.8M +57.09% | 45.7M +0.42% | |
Cash Flow | |||||
Cash from Operating Activities | -39.4M -271.39% | 23.0M +192.90% | -24.7M -127.56% | 89.8M +185.87% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -29.5M -71.32% | -102.8M +562.85% | -15.5M +461.75% | -2.8M -137.93% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -16.8M -118.81% | 89.1M +7.54% | 82.9M +7,137.12% | 1.1M -97.59% | |
Financials Ratio | |||||
Gross Margin | 100.00% 0.00% | 100.00% +4,094.45% | 2.38% -97.37% | 90.76% +100.51% | |
Operating Margin | -45.34% -68.40% | -143.49% -98.89% | -12,887.68% +2,655.45% | -467.72% +105.06% | |
Return on Assets | -19.09% +86.35% | -10.24% -71.88% | -36.42% +2.73% | -35.45% +20.66% | |
Return on Equity | -65.33% +91.69% | -34.08% -66.90% | -102.97% +63.62% | -62.93% +37.15% | |
Revenue Growth | 75.76% -98.60% | 5,397.35% +5,718.62% | -96.06% +44.37% | -66.54% +195.42% | |
Current Ratio | N/A N/A | 0.20 +478.95% | 0.03 -98.65% | 2.54 -44.49% | |
Cash Ratio | 0.42 -51.00% | 0.86 -2.22% | 0.88 -52.76% | 1.87 -50.41% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow